The Pharma Letter19h
EMA/CHMP backs bumper crop of new medicines for approval
The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended another batch medicines for approval at ...
FiercePharma22h
EMA backs Merck’s Welireg, Bayer’s ATTR med and Gilead’s liver drug from $4.3B deal
Merck & Co.’s kidney cancer drug Welireg, Bayer and BridgeBio’s transthyretin amyloid cardiomyopathy (ATTR-CM) therapy, and ...
manilatimes23h
Acoramidis Receives Positive CHMP Opinion for Treatment of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
The Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of acoramidis in the EU based on ...
manilatimes23h
AGF Management Limited Declares Fourth Quarter 2024 Dividend
TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- On December 13, 2024, the Board of Directors of AGF Management Limited declared a ...
BridgeBio Pharma Announces CHMP's Positive Recommendation Of Acoramidis - Quick Facts
BridgeBio Pharma (BBIO) announced the Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion ...
Bayer Gets EU Backing for Heart Drug, Easing Patent Concerns
Bayer AG won the backing of European Union regulators for its cardiology drug as the German company fights to offset the ...